The Tick and Flea Repellent market outlook remains robust, driven by rising pet ownership, increasing awareness of zoonotic diseases, and regulatory support for veterinary health innovations. Market attractiveness is elevated by untapped potential in emerging economies and the shift toward premium, long-acting formulations. Competitive intensity is high, with established players like Bayer, Ceva, and Zoetis dominating, but niche opportunities exist for bio-based and eco-friendly solutions. The long-term outlook is optimistic, underpinned by climate change-driven parasite proliferation and the humanization of pets fueling demand for advanced protection. The innovation landscape is dynamic, with advancements in slow-release technologies, combination therapies, and non-toxic ingredients reshaping product portfolios. Demand–supply balance remains stable, though raw material volatility and production bottlenecks pose intermittent risks. Key risk factors include stringent regulatory scrutiny, litigation over product safety, and counterfeit product infiltration in unregulated markets. Strategic differentiation through R&D and geographic expansion will define success in this evolving sector.